SEC Form 4 · accession 0001654954-18-007370
TG THERAPEUTICS, INC. · TGTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sean A Power
Officer — CFO, Secretary and Treasurer
Period of report
Jul 2, 2018
Accepted (ET)
Jul 5, 2018 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001001316
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCKF2 | Jul 2, 2018 | S | 12,191 | $13.26 | D | 473,267 | D | |
| COMMON STOCKF3 | Jul 3, 2018 | S | 35,000 | $13.19 | D | 438,267 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1In connection with the vesting of 25,000 shares on June 30, 2018, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
- F2Represents the weighted average sales price.
- F3Includes shares of restricted Common Stock, which vest over various time periods.